Image_10_The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria In.tif (978.57 kB)
Download fileImage_10_The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection.tif
figure
posted on 2020-04-28, 13:27 authored by Ying Du, Ethan G. Thompson, Julius Muller, Joseph Valvo, Jackie Braun, Smitha Shankar, Robert A. van den Berg, Erik Jongert, Drew Dover, Jerald Sadoff, Jenny Hendriks, Malcolm J. Gardner, W. Ripley Ballou, Jason A. Regules, Robbert van der Most, Alan Aderem, Christian F. Ockenhouse, Adrian V. Hill, Ulrike Wille-Reece, Daniel E. ZakThe RTS,S/AS01 vaccine provides partial protection against Plasmodium falciparum infection but determinants of protection and/or disease are unclear. Previously, anti-circumsporozoite protein (CSP) antibody titers and blood RNA signatures were associated with RTS,S/AS01 efficacy against controlled human malaria infection (CHMI). By analyzing host blood transcriptomes from five RTS,S vaccination CHMI studies, we demonstrate that the transcript ratio MX2/GPR183, measured 1 day after third immunization, discriminates protected from non-protected individuals. This ratiometric signature provides information that is complementary to anti-CSP titer levels for identifying RTS,S/AS01 immunized people who developed protective immunity and suggests a role for interferon and oxysterol signaling in the RTS,S mode of action.
History
References
- https://doi.org//10.1111/febs.14107
- https://doi.org//10.1086/600120
- https://doi.org//10.1371/journal.pone.0131571
- https://doi.org//10.1093/infdis/jiw237
- https://doi.org//10.1093/infdis/jiw244
- https://doi.org//10.1038/s41541-018-0084-2
- https://doi.org//10.1016/S0140-6736(15)60721-8
- https://doi.org//10.1038/s41467-019-10195-z
- https://doi.org//10.3389/fimmu.2017.01839
- https://doi.org//10.1080/14760584.2019.1580577
- https://doi.org//10.1182/bloodadvances.2017011411
- https://doi.org//10.1093/infdis/jiq156
- https://doi.org//10.1038/ni.2789
- https://doi.org//10.1073/pnas.1519690113
- https://doi.org//10.3390/vaccines8010004
- https://doi.org//10.1038/ni.1688
- https://doi.org//10.1086/650310
- https://doi.org//10.1073/pnas.1621489114
- https://doi.org//10.3389/fimmu.2017.00557
- https://doi.org//10.12688/f1000research.7093.1
- https://doi.org//10.1016/j.vaccine.2015.07.087
- https://doi.org//10.1016/S2213-2600(16)00048-5
- https://doi.org//10.1126/scitranslmed.aaf7165
- https://doi.org//10.1164/rccm.201711-2340OC
- https://doi.org//10.3389/fimmu.2019.02616
- https://doi.org//10.1016/j.tube.2017.08.004
- https://doi.org//10.1093/bioinformatics/bts635
- https://doi.org//10.1093/bioinformatics/btu638
- https://doi.org//10.1093/bioinformatics/btp616
- https://doi.org//10.1016/j.immuni.2012.12.008
- https://doi.org//10.1093/nar/gkz1031
- https://doi.org//10.1016/j.cels.2015.12.004
- https://doi.org//10.1016/S0140-6736(15)01316-1
- https://doi.org//10.1006/meth.2001.1262
- https://doi.org//10.1038/nature18003
- https://doi.org//10.1016/j.cell.2019.08.052
- https://doi.org//10.15252/msb.20188503
- https://doi.org//10.1101/632216
- https://doi.org//10.1126/science.aah4573
- https://doi.org//10.1038/s41467-019-13056-x
- https://doi.org//10.1101/gr.1239303
- https://doi.org//10.3389/fimmu.2017.00943
- https://doi.org//10.1080/21645515.2017.1381809
- https://doi.org//10.1186/s12977-017-0380-3
- https://doi.org//10.3390/cancers12010077
- https://doi.org//10.1159/000486585
- https://doi.org//10.1172/JCI125372
- https://doi.org//10.1172/JCI78280
- https://doi.org//10.4049/jimmunol.1101764
- https://doi.org//10.1016/j.smim.2018.08.001
- https://doi.org//10.1038/nature09386
- https://doi.org//10.1371/journal.pone.0083457
- https://doi.org//10.3389/fphar.2015.00060
- https://doi.org//10.1038/ni.2555
- https://doi.org//10.1038/nature17947
- https://doi.org//10.1126/sciimmunol.aal5237
- https://doi.org//10.3389/fimmu.2018.03006
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity
CC BY 4.0